Statistics
Publications
2
Citations
21
H-Index
2
Active since
2024
Affiliations
Rigshospitalet(Current)
Ida Elisabeth Viller Tuxen is an author at Rigshospitalet specializing in metastatic cancer management, cyclin-dependent kinase 6 inhibitors, and patient dose reduction.
Publications per year
2024–2025
2
2
Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer
Andreas Bjerrum, A.F. Henriksen, Ann Knoop et al. · BJC Reports · 2024 · 10 citations · Full text
Medicine, Oncology, Pharmacology +17
1–2 of 2